What's breaking now, across thousands of outlets.
Kaos Capital wants a “governance reset” to alter the Duchenne cell therapy maker’s strategic course. Elsewhere, Bristol Myers furthered efforts to build an “AI-powered” discovery engine.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The study is among the first to examine the brain's superficial white matter in a community-based population from a low- and middle-income country
The study is among the first to examine the brain's superficial white matter in a community-based population from a low- and middle-income country
Epidemic remains out of control amid DR Congo conflict, funding shortages and attacks on health workers and facilities
Kenyatta National Hospital (KNH) advised patients seeking non-emergency medical care to consider other health facilities as the national referral hospital grapples with a surge in patient numbers and…
The wildfires this summer have broken records in Germany and are unlikely to subside in future. Psychologists say post-traumatic stress disorder caused by such disasters is serious but can be treated…
